245 related articles for article (PubMed ID: 37012874)
1. Advances in antibody-based drugs and their delivery through the blood-brain barrier for targeted therapy and immunotherapy of gliomas.
Huang X; Shi S; Wang H; Zhao T; Wang Y; Huang S; Su Y; Zhao C; Yang M
Int Immunopharmacol; 2023 Apr; 117():109990. PubMed ID: 37012874
[TBL] [Abstract][Full Text] [Related]
2. Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.
van Tellingen O; Yetkin-Arik B; de Gooijer MC; Wesseling P; Wurdinger T; de Vries HE
Drug Resist Updat; 2015 Mar; 19():1-12. PubMed ID: 25791797
[TBL] [Abstract][Full Text] [Related]
3. Drug delivery strategies to enhance the permeability of the blood-brain barrier for treatment of glioma.
Zhang F; Xu CL; Liu CM
Drug Des Devel Ther; 2015; 9():2089-100. PubMed ID: 25926719
[TBL] [Abstract][Full Text] [Related]
4. The blood-brain/tumor barriers: challenges and chances for malignant gliomas targeted drug delivery.
Zhan C; Lu W
Curr Pharm Biotechnol; 2012 Sep; 13(12):2380-7. PubMed ID: 23016643
[TBL] [Abstract][Full Text] [Related]
5. A simple self-assembly nanomicelle based on brain tumor-targeting peptide-mediated siRNA delivery for glioma immunotherapy via intranasal administration.
Tang L; Zhang R; Wang Y; Zhang X; Yang Y; Zhao B; Yang L
Acta Biomater; 2023 Jan; 155():521-537. PubMed ID: 36384220
[TBL] [Abstract][Full Text] [Related]
6. LDL receptors and their role in targeted therapy for glioma: a review.
Pawar S; Koneru T; McCord E; Tatiparti K; Sau S; Iyer AK
Drug Discov Today; 2021 May; 26(5):1212-1225. PubMed ID: 33609780
[TBL] [Abstract][Full Text] [Related]
7. Novel chemotherapeutics and other therapies for treating high-grade glioma.
Kang JH; Adamson C
Expert Opin Investig Drugs; 2015; 24(10):1361-79. PubMed ID: 26289791
[TBL] [Abstract][Full Text] [Related]
8. Targeted Therapeutics in Patients With High-Grade Gliomas: Past, Present, and Future.
Chen R; Cohen AL; Colman H
Curr Treat Options Oncol; 2016 Aug; 17(8):42. PubMed ID: 27334978
[TBL] [Abstract][Full Text] [Related]
9. Delivery of molecularly targeted therapy to malignant glioma, a disease of the whole brain.
Agarwal S; Sane R; Oberoi R; Ohlfest JR; Elmquist WF
Expert Rev Mol Med; 2011 May; 13():e17. PubMed ID: 21676290
[TBL] [Abstract][Full Text] [Related]
10. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
11. Targeted brain delivery nanoparticles for malignant gliomas.
Pinto MP; Arce M; Yameen B; Vilos C
Nanomedicine (Lond); 2017 Jan; 12(1):59-72. PubMed ID: 27876436
[TBL] [Abstract][Full Text] [Related]
12. Research Progress on Nanoplatforms and Nanotherapeutic Strategies in Treating Glioma.
Qiao L; Yang H; Shao XX; Yin Q; Fu XJ; Wei Q
Mol Pharm; 2022 Jul; 19(7):1927-1951. PubMed ID: 35499303
[TBL] [Abstract][Full Text] [Related]
13. Low-intensity ultrasound: A novel technique for adjuvant treatment of gliomas.
Fang Y; Zhang G; Bai Z; Yan Y; Song X; Zhao X; Yang P; Zhang Z
Biomed Pharmacother; 2022 Sep; 153():113394. PubMed ID: 36036428
[TBL] [Abstract][Full Text] [Related]
14. Nanoparticle-mediated drug delivery to high-grade gliomas.
Frosina G
Nanomedicine; 2016 May; 12(4):1083-1093. PubMed ID: 26767516
[TBL] [Abstract][Full Text] [Related]
15. Ligand-modified homologous targeted cancer cell membrane biomimetic nanostructured lipid carriers for glioma therapy.
Chen M; Cui Y; Hao W; Fan Y; Zhang J; Liu Q; Jiang M; Yang Y; Wang Y; Gao C
Drug Deliv; 2021 Dec; 28(1):2241-2255. PubMed ID: 34668811
[TBL] [Abstract][Full Text] [Related]
16. Endovascular therapies for malignant gliomas: Challenges and the future.
Su YS; Ali R; Feroze AH; Li G; Lawton MT; Choudhri O
J Clin Neurosci; 2016 Apr; 26():26-32. PubMed ID: 26857294
[TBL] [Abstract][Full Text] [Related]
17. Nanoparticle Drug Delivery System for Glioma and Its Efficacy Improvement Strategies: A Comprehensive Review.
Li J; Zhao J; Tan T; Liu M; Zeng Z; Zeng Y; Zhang L; Fu C; Chen D; Xie T
Int J Nanomedicine; 2020; 15():2563-2582. PubMed ID: 32368041
[TBL] [Abstract][Full Text] [Related]
18. Smart Nanomedicine to Enable Crossing Blood-Brain Barrier Delivery of Checkpoint Blockade Antibody for Immunotherapy of Glioma.
Wang H; Chao Y; Zhao H; Zhou X; Zhang F; Zhang Z; Li Z; Pan J; Wang J; Chen Q; Liu Z
ACS Nano; 2022 Jan; 16(1):664-674. PubMed ID: 34978418
[TBL] [Abstract][Full Text] [Related]
19. Image-guided chemotherapy with specifically tuned blood brain barrier permeability in glioma margins.
Gao X; Yue Q; Liu Y; Fan D; Fan K; Li S; Qian J; Han L; Fang F; Xu F; Geng D; Chen L; Zhou X; Mao Y; Li C
Theranostics; 2018; 8(11):3126-3137. PubMed ID: 29896307
[TBL] [Abstract][Full Text] [Related]
20. Overcoming the Blood-Brain Barrier: Successes and Challenges in Developing Nanoparticle-Mediated Drug Delivery Systems for the Treatment of Brain Tumours.
Ferraris C; Cavalli R; Panciani PP; Battaglia L
Int J Nanomedicine; 2020; 15():2999-3022. PubMed ID: 32431498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
